Matinas Biopharma Holdings, Inc. (AMEX:MTNB) headquartered in Bedminster, will host a conference call for the investment community to discuss the 2Q20 financial results on 10th August 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.matinasbiopharma.com
Earnings Expectation
Matinas Biopharma Holdings, Inc. is reporting second quarter financial results on Monday 10th August 2020, after market close.
According to analysts surveyed by Thomson Reuters, MTNB is expected to report 2Q20 loss of $ 0.03 per share from revenue of $ 0.02 million. For the full year, analysts anticipate top line of $ 1.07 million, while looking forward to loss of $ 0.13 per share bottom line.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company develops products using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals, which could encapsulate small molecules, gene therapies, vaccines, proteins, and peptides.
